Project Grant R34CA297368
Award Date
4/1/25
Completion Date
3/31/28
Dollars Obligated
$317K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) is providing $757,913 to the Fred Hutchinson Cancer Center in Seattle, Washington to conduct a randomized controlled trial evaluating the efficacy and cost-effectiveness of providing a smoking cessation smartphone app (iCanQuit) combined with free nicotine replacement therapy (NRT) versus the app alone for Hispanic adults. The goal is to determine...
This $257,415 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) will fund the development and pilot testing of an AI-enhanced, smartphone app-based intervention for adolescent e-cigarette cessation. The award recipient, The Research Foundation for the State University of New York, will create a scalable, personalized app-based intervention that utilizes artificial intelligence to deliver tailored cessation content and messages...
The National Cancer Institute (NCI) awarded a $653,951 Cooperative Agreement under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center. The purpose of this 5-year award is to implement and evaluate sustainable mobile health (mHealth) technology to optimize a smoking cessation program for people with HIV in Laos.
Specifically, the project will compare two strategies for delivering evidence-based smoking cessation interventions...
The National Cancer Institute (NCI) awarded a $1,003,164 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Yale University to evaluate the feasibility and efficacy of a smartphone-based cognitive-behavioral therapy (CBT) app, called "Kick-NIC!," for supporting e-cigarette cessation among adolescents. The 5-year grant, beginning September 1, 2024, will fund a randomized controlled trial to assess the app's impact on reducing e-cigarette use among 306 high school...
The National Cancer Institute (NCI) awarded a $279,573 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Houston System to refine and test a novel smoking cessation intervention that integrates olfactory stimulation to reduce cigarette cravings with an established smartphone-based smoking cessation application. The project aims to (1) refine the design and methodology for the olfactory stimulation delivery system and (2) determine the adjunctive benefit...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $625,201 to the University of Oklahoma Health Sciences Center to conduct a 5-year randomized clinical trial. The study aims to evaluate the effectiveness of combining the smoking cessation medication varenicline with nicotine lozenges, along with a smartphone-based medication adherence intervention, to improve smoking cessation rates among...
The National Cancer Institute (NCI) awarded a $766,773 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the Dana-Farber Cancer Institute, Inc. (DFCI) for the project "Inclusion of Diverse and Medically Underserved Populations in the Design and Implementation of the PREMMPLUS Patient-Facing App." The grant aims to evaluate a patient-facing mobile app version of the PREMMPLUS multigene cancer risk assessment model in diverse community health...
The National Cancer Institute (NCI) awarded a $1,128,600 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Utah to develop and evaluate a mobile health (mHealth) app called "Color Me Healthy" that supports symptom communication for children with cancer during early cancer treatment. The funding will be used to create a clinician-facing version of the app that integrates with electronic health record (EHR) systems, optimizing the implementation...
The National Cancer Institute (NCI) awarded a $1,226,040 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the Regents of the University of Minnesota to conduct a randomized clinical trial of a culturally-tailored suite of smoking cessation resources for American Indian persons.
The project aims to: 1) Co-create a culturally-aligned website, "Smokefree.gov for Natives," to serve as the landing page for online cessation treatment content and...
This $667,828 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) seeks to enhance the reach and effectiveness of tobacco quitline services for socioeconomically disadvantaged populations.
The project will adapt the evidence-based Ask-Advise-Connect (AAC) model for implementation within community-based food pantry settings, conducting a cluster randomized trial to evaluate the reach and effectiveness of the adapted...